Therapeutic advantage of recombinant human plasminogen activator in endocarditis: Evidence from experiments in rabbits

M. W. Meyer, A. R. Witt, L. K. Krishnan, M. Yokota, M. J. Roszkowski, J. D. Rudney, M. C. Herzberg

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Therapeutic advantage of recombinant human plasminogen activator in endocarditis: Evidence from experiments in rabbits'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science